Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
British Journal of Pharmacology
|
June 29, 2001
Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells
J Tsukada, A Tahara, Y Tomura, et al.
American Heart Journal
|
April 1, 1990
Circulating immunoreactive endothelin in ischemic heart disease
M Yasuda, M Kohno, A Tahara, et al.
American Heart Journal
|
October 1, 1991
Plasma levels of platelet-derived growth factor in normal subjects and patients with ischemic heart disease
A Tahara, M Yasuda, H Itagane, et al.
Circulation
|
January 1, 1990
The complement system in ischemic heart disease
M Yasuda, K Takeuchi, M Hiruma, et al.
Japanese Circulation Journal
|
November 1, 1992
Clinical significance of reverse redistribution on thallium-201 single-photon emission computed tomography in patients with acute myocardial infarction
H Yamagishi, H Itagane, K Akioka, et al.
British Journal of Pharmacology
|
January 12, 1999
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells
A Tahara, M Saito, T Sugimoto, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
February 12, 1998
Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist
A Tahara, M Saito, T Sugimoto, et al.
Pflugers Archiv : European Journal of Physiology
|
February 4, 1999
AVP-induced mitogenic responses of Chinese hamster ovary cells expressing human V1A or V1B receptors
A Tahara, M Saito, T Sugimoto, et al.
European Journal of Pharmacology
|
August 17, 1999
Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure
T Yatsu, Y Tomura, A Tahara, et al.
Nippon Ganka Gakkai Zasshi
|
January 22, 1998
[Intraocular neovascularization]
H Inomata, T Ishibashi, T Murata, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
British Journal of Pharmacology
|
June 29, 2001
Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells
J Tsukada, A Tahara, Y Tomura, et al.
American Heart Journal
|
April 1, 1990
Circulating immunoreactive endothelin in ischemic heart disease
M Yasuda, M Kohno, A Tahara, et al.
American Heart Journal
|
October 1, 1991
Plasma levels of platelet-derived growth factor in normal subjects and patients with ischemic heart disease
A Tahara, M Yasuda, H Itagane, et al.
Circulation
|
January 1, 1990
The complement system in ischemic heart disease
M Yasuda, K Takeuchi, M Hiruma, et al.
Japanese Circulation Journal
|
November 1, 1992
Clinical significance of reverse redistribution on thallium-201 single-photon emission computed tomography in patients with acute myocardial infarction
H Yamagishi, H Itagane, K Akioka, et al.
British Journal of Pharmacology
|
January 12, 1999
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells
A Tahara, M Saito, T Sugimoto, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
February 12, 1998
Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist
A Tahara, M Saito, T Sugimoto, et al.
Pflugers Archiv : European Journal of Physiology
|
February 4, 1999
AVP-induced mitogenic responses of Chinese hamster ovary cells expressing human V1A or V1B receptors
A Tahara, M Saito, T Sugimoto, et al.
European Journal of Pharmacology
|
August 17, 1999
Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure
T Yatsu, Y Tomura, A Tahara, et al.
Nippon Ganka Gakkai Zasshi
|
January 22, 1998
[Intraocular neovascularization]
H Inomata, T Ishibashi, T Murata, et al.
Page
of 4